Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Alan F. List
Cost Effectiveness of Lenalidomide in the Treatment of Transfusion-Dependent Myelodysplastic Syndromes in the United States
Cancer Control
Medicine
Oncology
Hematology
‹
1
2
Related publications
Impact of Lenalidomide Use Among Non-Transfusion Dependent Patients With Myelodysplastic Syndromes
American Journal of Hematology
Hematology
Cost-Effectiveness in Canada of Azacitidine for the Treatment of Higher-Risk Myelodysplastic Syndromes
Current Oncology
Oncology
Management of Cytopenias During Treatment With Lenalidomide in Patients With Myelodysplastic Syndromes
The Open Leukemia Journal
A Calcium- And Calpain-Dependent Pathway Determines the Response to Lenalidomide in Myelodysplastic Syndromes
Nature Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Practical Considerations in the Use of Lenalidomide Therapy for Myelodysplastic Syndromes
Cancer Control
Medicine
Oncology
Hematology
Developments in the Treatment of Transfusion-Dependent Anemia in Patients With Myelodysplastic Syndromes: Epidemiology, Etiology, Genetics, and Targeted Therapies
Advances in Genomics and Genetics
Hematologic Responses to Deferasirox Therapy in Transfusion-Dependent Patients With Myelodysplastic Syndromes
Haematologica
Hematology
Lenalidomide: Targeted Anemia Therapy for Myelodysplastic Syndromes
Cancer Control
Medicine
Oncology
Hematology
Cost-Effectiveness of Alemtuzumab in the Treatment of Relapsing Forms of Multiple Sclerosis in the United States
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
